Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons

Margaret M. Tompkins, Edward J. Basgall, Edward Zamrini, William D. Hill

Research output: Contribution to journalArticle

231 Citations (Scopus)

Abstract

In Parkinson's disease and other Lewy-body-associated disorders, the substantia nigra pars compacta undergoes degeneration, but the mechanism of cell death has not been previously described. The substantia nigra of normal and Alzheimer's disease cases were compared with substantia nigra from patients with Lewy-body-associated disorders (Parkinson's disease, concomitant Alzheimer's/Parkinson's disease, and diffuse Lewy body disease) using in situ end labeling to detect fragmented DNA. In situ end-labeled neurons demonstrated changes resembling apoptosis: nuclear condensation, chromatin fragmentation, and formation of apoptotic-like bodies. Ultrastructural analysis confirmed nuclear condensation and formation of apoptotic-like bodies. Apoptotic-like changes were seen in the substantia nigra of both normal and diseased cases; concomitant Alzheimer's/Parkinson's disease and diffuse Lewy body disease cases had significantly higher amounts of apoptotic-like changes than normal controls or Alzheimer patients. The finding of neuronal death by apoptosis may have relevance for the development of new treatment strategies for Parkinson's disease and related disorders.

Original languageEnglish (US)
Pages (from-to)119-131
Number of pages13
JournalAmerican Journal of Pathology
Volume150
Issue number1
StatePublished - Jan 21 1997

Fingerprint

Lewy Bodies
Substantia Nigra
Parkinson Disease
Neurons
Lewy Body Disease
Alzheimer Disease
Apoptosis
Chromatin
Cell Death
DNA

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Tompkins, M. M., Basgall, E. J., Zamrini, E., & Hill, W. D. (1997). Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. American Journal of Pathology, 150(1), 119-131.

Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. / Tompkins, Margaret M.; Basgall, Edward J.; Zamrini, Edward; Hill, William D.

In: American Journal of Pathology, Vol. 150, No. 1, 21.01.1997, p. 119-131.

Research output: Contribution to journalArticle

Tompkins, MM, Basgall, EJ, Zamrini, E & Hill, WD 1997, 'Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons', American Journal of Pathology, vol. 150, no. 1, pp. 119-131.
Tompkins, Margaret M. ; Basgall, Edward J. ; Zamrini, Edward ; Hill, William D. / Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. In: American Journal of Pathology. 1997 ; Vol. 150, No. 1. pp. 119-131.
@article{c036d75da4ce4534873c2f468ec272eb,
title = "Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons",
abstract = "In Parkinson's disease and other Lewy-body-associated disorders, the substantia nigra pars compacta undergoes degeneration, but the mechanism of cell death has not been previously described. The substantia nigra of normal and Alzheimer's disease cases were compared with substantia nigra from patients with Lewy-body-associated disorders (Parkinson's disease, concomitant Alzheimer's/Parkinson's disease, and diffuse Lewy body disease) using in situ end labeling to detect fragmented DNA. In situ end-labeled neurons demonstrated changes resembling apoptosis: nuclear condensation, chromatin fragmentation, and formation of apoptotic-like bodies. Ultrastructural analysis confirmed nuclear condensation and formation of apoptotic-like bodies. Apoptotic-like changes were seen in the substantia nigra of both normal and diseased cases; concomitant Alzheimer's/Parkinson's disease and diffuse Lewy body disease cases had significantly higher amounts of apoptotic-like changes than normal controls or Alzheimer patients. The finding of neuronal death by apoptosis may have relevance for the development of new treatment strategies for Parkinson's disease and related disorders.",
author = "Tompkins, {Margaret M.} and Basgall, {Edward J.} and Edward Zamrini and Hill, {William D.}",
year = "1997",
month = "1",
day = "21",
language = "English (US)",
volume = "150",
pages = "119--131",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons

AU - Tompkins, Margaret M.

AU - Basgall, Edward J.

AU - Zamrini, Edward

AU - Hill, William D.

PY - 1997/1/21

Y1 - 1997/1/21

N2 - In Parkinson's disease and other Lewy-body-associated disorders, the substantia nigra pars compacta undergoes degeneration, but the mechanism of cell death has not been previously described. The substantia nigra of normal and Alzheimer's disease cases were compared with substantia nigra from patients with Lewy-body-associated disorders (Parkinson's disease, concomitant Alzheimer's/Parkinson's disease, and diffuse Lewy body disease) using in situ end labeling to detect fragmented DNA. In situ end-labeled neurons demonstrated changes resembling apoptosis: nuclear condensation, chromatin fragmentation, and formation of apoptotic-like bodies. Ultrastructural analysis confirmed nuclear condensation and formation of apoptotic-like bodies. Apoptotic-like changes were seen in the substantia nigra of both normal and diseased cases; concomitant Alzheimer's/Parkinson's disease and diffuse Lewy body disease cases had significantly higher amounts of apoptotic-like changes than normal controls or Alzheimer patients. The finding of neuronal death by apoptosis may have relevance for the development of new treatment strategies for Parkinson's disease and related disorders.

AB - In Parkinson's disease and other Lewy-body-associated disorders, the substantia nigra pars compacta undergoes degeneration, but the mechanism of cell death has not been previously described. The substantia nigra of normal and Alzheimer's disease cases were compared with substantia nigra from patients with Lewy-body-associated disorders (Parkinson's disease, concomitant Alzheimer's/Parkinson's disease, and diffuse Lewy body disease) using in situ end labeling to detect fragmented DNA. In situ end-labeled neurons demonstrated changes resembling apoptosis: nuclear condensation, chromatin fragmentation, and formation of apoptotic-like bodies. Ultrastructural analysis confirmed nuclear condensation and formation of apoptotic-like bodies. Apoptotic-like changes were seen in the substantia nigra of both normal and diseased cases; concomitant Alzheimer's/Parkinson's disease and diffuse Lewy body disease cases had significantly higher amounts of apoptotic-like changes than normal controls or Alzheimer patients. The finding of neuronal death by apoptosis may have relevance for the development of new treatment strategies for Parkinson's disease and related disorders.

UR - http://www.scopus.com/inward/record.url?scp=0031013141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031013141&partnerID=8YFLogxK

M3 - Article

VL - 150

SP - 119

EP - 131

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 1

ER -